Bleakley Financial Group, LLC Laboratory Corp Of America Holdings Transaction History

Bleakley Financial Group, LLC

6 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2024 May 08, 2024	SELL	$209.01 - $232.56 $83,604 - $93,024	-400 Reduced 17.32%	1,910 $417 Million
Q4 2023 Jan 25, 2024	BUY	$197.69 - $227.29 $12,652 - $14,546	64 Added 2.85%	2,310 $525 Million
Q3 2023 Nov 14, 2023	SELL	$201.05 - $221.7 $6.93 Million - $7.64 Million	-34,448 Reduced 93.88%	2,246 $452 Million
Q2 2023 Aug 14, 2023	BUY	$211.93 - $241.33 $2.16 Million - $2.46 Million	10,193 Added 38.46%	36,694 $8.86 Billion
Q1 2023 May 12, 2023	BUY	$213.32 - $257.83 $104,100 - $125,821	488 Added 1.88%	26,501 $6.08 Billion
Q4 2022 Feb 07, 2023	BUY	$203.72 - $248.97 $5.3 Million - $6.48 Million	26,013 New	26,013 $6.13 Billion

1.94M

Ticker LH
Exchange NYSE
Sector Healthcare
Industry Diagnostics & Research
Shares Outstandng 89,600,000
Market Cap $20.5B
Description
Laboratory Corporation of America Holdings operates as a global life sciences company that provides vital information to help doctors, hospitals, pharmaceutical companies, researchers, and patients make clear and confident decisions. It operates in two segments, Labcorp Diagnostics (Dx) and Labcorp Drug Development (DD). It offers various tests,...

Get notified when there are updates to the investment portfolio of Bleakley Financial Group, LLC, based on Form 13F filings with the SEC.

Stay updated on Bleakley Financial Group, LLC with notifications on news.